GSK

GSKNYSE United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$103.320 B

$51.08 +1.71%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

4,315,445,026

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#11Bristol Myers SquibbBMY$127.9B
#12SanofiSNY$103.7B
#13GSKGSK$103.3B
#14Regeneron PharmaceuticalsREGN$82.2B
#15Takeda PharmaceuticalTAK$59.7B

What if GSK were worth as much as…

Open the what-if tool →

Gold $30.3T

$14,967.11

Per share 293× higher

Bitcoin $1.72T

$850.25

Per share 16.6× higher

Nvidia $5.48T

$2,709.17

Per share 53.0× higher

Or at a round number

$200.0B $500.0B $1.00T $2.00T

Where these numbers come from

Share counts and financials for GSK are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.